A Previously Unknown Unique Challenge for Inhibitors of SYK ATP-Binding Site: Role of SYK as A Cell Cycle Checkpoint Regulator

The identification of SYK as a molecular target in B-lineage leukemia/lymphoma cells prompted the development of SYK inhibitors as a new class of anti-cancer drug candidates. Here we report that induction of the SYK gene expression in human cells causes a significant down-regulation of evolutionaril...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Fatih M. Uckun, Hong Ma, Zahide Ozer, Patricia Goodman, Jian Zhang, Sanjive Qazi
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Elsevier 2014-11-01
Saila:EBioMedicine
Gaiak:
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S2352396414000218